Home | Structured Search | Drug Resource
Find: within
Mammalian Bites > Hospitalization Author: Jeffrey D. Kravetz, MD; Daniel G. Federman, MD
Editorial changes - 2008-01-23
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Infected tendons, bones, or septic arthritis are difficult to eradicate with outpatient management alone.
  • Outpatient management of infected human hand bites usually fails and ultimately leads to delayed hospitalization.
  • Clenched fist wounds often appear as small lacerations, 3 to 5 mm in length on the surface, but often involve deep structures of the hand.
  • Insufficient debridement and cleansing of human hand bite wounds by emergency department personnel not experienced in hand bite management can lead to under-treatment of hand wounds, ultimately increasing morbidity.

Evidence:

  • A retrospective review of eight patients admitted for human hand bite infections showed that management failed in six patients initially treated in the outpatient setting, including treatment with oral antibiotics (34).
  • In a prospective study of 100 human “fight-bite” injuries of the hand, the time till admission of the 18 who ultimately required amputation was 9.2 days in comparison to 4.6 days in those with healing without amputation (23).
  • Twenty-three of 24 patients admitted with hand osteomyelitis from a human bite wound did not receive adequate surgical debridement within 24 hours of the injury (29).

Comments:

  • None.

FAQs
Daniel G. Federman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Jeffrey D. Kravetz, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.